Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women

NCT00705679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5029

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Emtricitabine/tenofovir disoproxil fumarate
DRUG: Emtricitabine/tenofovir disoproxil fumarate placebo
DRUG: Tenofovir disoproxil fumarate
DRUG: Tenofovir disoproxil fumarate placebo
DRUG: Tenofovir 1% vaginal gel
DRUG: Tenofovir placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]